RECQL4 and cancer: Biallelic mutations in these RecQ homologs, WRN, BLM, and RECQL4, have been previously reported to be associated with rare human genetic diseases characterized by chromosomal instability and cancer susceptibility (Croteau et al., 2014; Thakkar et al., 2022).